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Abstract
We present a framework, which we call Molecule Deep Q-Networks (MolDQN), for
molecule optimization by combining domain knowledge of chemistry and state-of-the-
art reinforcement learning techniques (double Q-learning and randomized value func-
tions). We directly define modifications on molecules, thereby ensuring 100% chemical
validity. Further, we operate without pre-training on any dataset to avoid possible bias
from the choice of that set. Inspired by problems faced during medicinal chemistry lead
optimization, we extend our model with multi-objective reinforcement learning, which
maximizes drug-likeness while maintaining similarity to the original molecule. We fur-
ther show the path through chemical space to achieve optimization for a molecule to
understand how the model works.
KEYWORDS: Molecule Optimization, Reinforcement Learning, Learning from
Scratch, Multi-Objective Optimization
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1 Introduction
One fundamental goal in chemistry is to design new molecules with specific desired properties.
This is especially important in material design or drug screening. Currently, this process is
expensive in terms of time and cost: It can take years and cost millions of dollars to find a
new drug.1 The goal of this study is to partially automate this process through reinforcement
learning.
To appreciate our approach, it is necessary to review briefly the previous works that
employed machine learning in molecule design. One prevalent strategy is to build a generative
model, which maps a point in a high-dimensional latent space to a molecule, and perform
search or optimization in the latent space to find new molecules. Go´mez-Bombarelli et al. 2 ,
Blaschke et al. 3 , Segler et al. 4 , Lim et al. 5 , and Putin et al. 6 utilized strings as molecule
representations to build a generator of SMILES7 strings, which is a linear string notation to
describe molecular structures. One of the most challenging goals in this design is to ensure
the chemical validity of the generated molecules. Kusner et al. 8 and Dai et al. 9 added
grammar constraints to SMILES strings to improve the chemical validity of the generated
molecules. Researchers have also built models on graph representations of molecules, which
regards atoms as nodes and bonds as edges in an undirected graph. Li et al. 10 and Li et al. 11
described molecule generators that create graphs in a step-wise manner. De Cao and Kipf 12
introduced MolGAN for generating small molecular graphs. Jin et al. 13 designed a two-step
generation process in which a tree is first constructed to represent the molecular scaffold
and then expanded to a molecule. Although almost perfect on generating valid molecules,
these autoencoder-based models usually need to address the problem of optimization. Most
published work uses a separate Gaussian process model on the latent space for optimization.
However, because the latent space is often high dimensional and the objective functions
defined on the latent space is usually non-convex, molecule property optimization on the
latent space can be difficult.
Another strategy is based on reinforcement learning, which is a sub-field of artificial
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intelligence. Reinforcement learning studies the way to make decisions to achieve the highest
reward. Olivecrona et al. 14 , Guimaraes et al. 15 , Putin et al. 16 , and Popova et al. 17 applied
reinforcement learning techniques on top of a string generator to generate the SMILES strings
of molecules. They successfully generated molecules with given desirable properties, but
struggled with chemical validity. Recently, You et al. 18 proposed a graph convolutional policy
network (GCPN) for generating graph representations of molecules with deep reinforcement
learning, achieving 100% validity. However, all these methods require pre-training on a
specific dataset. While pre-training makes it easier to generate molecules similar to the
given training set, the exploration ability is limited by the biases present in the training
data.
Here we introduce a new design for molecule optimization by combining chemistry domain
knowledge and reinforcement learning, which we call Molecule Deep Q-Networks (MolDQN).
We formulate the modification of a molecule as a Markov decision process (MDP).19 By
only allowing chemically valid actions, we ensure that all the molecules generated are valid.
We then employ the deep reinforcement learning technique of Deep Q-Networks (DQN)20 to
solve this MDP, using the desired properties as rewards. Instead of pre-training on a dataset,
our model learns from scratch. Additionally, with the introduction of multi-objective deep
reinforcement learning, our model is capable of performing multi-objective optimization.
Our contribution differs from previous work in three critical aspects:
1. All the works presented above use policy gradient methods, while ours is based on
value function learning. Although policy gradient methods are applicable to a wider
range of problems, they suffer from high variance when estimating the gradient.21 In
comparison, in applications where value function learning works, it is usually more
stable and sample efficient.20
2. Most, if not all, of the current algorithms rely on pre-training on some datasets. Al-
though expert pre-training may lead to lower variance, this approach limits the search
space and may miss the molecules which are not in the dataset. In contrast, our
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method starts from scratch and learns from its own experience, which can lead to
better performance, i.e., discovering molecules with better properties.
3. Our model is designed for multi-objective reinforcement learning, allowing users to
decide the relative importance of each objective. See 3.3 for more detail.
2 Methods
2.1 Molecule Modification as a Markov Decision Process
Intuitively, the modification or optimization of a molecule can be done in a step-wise fashion,
where each step belongs to one of the following three categories: (1) atom addition, (2) bond
addition, and (3) bond removal. The molecule generated is only dependent on the molecule
being changed and the modification made. Therefore, the process of molecule optimization
can be formulated as a Markov decision process (MDP). We have several key differences
from previous work that employed MDP for molecule modification.18
• We add an explicit limit on the number of steps. This allows us to easily control how
far away from a starting molecule we can go. In vast chemical space, this is a very
natural way to control the diversity of molecules produced.
• We do not allow chemically invalid actions (violations of valence constraints). These
actions are removed from the action space entirely and are not even considered by our
model.
• We allow atoms/bonds to be removed as well as added.
Formally, we have MDP(S,A, {Psa},R), where we define each term in what follows:
• S denotes the state space, in which each state s ∈ S is a tuple of (m, t). Here m is a
valid molecule and t is the number of steps taken. For the initial state, the molecule
m can be a specific molecule or nothing, and t = 0. We limit the maximum number
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of steps T that can be taken in this MDP. In other words, the set of terminal states is
defined as {s = (m, t)|t = T}, which consists of the states whose step number reaches
its maximum value.
• A denotes the action space, in which each action a ∈ A is a valid modification to a
specific molecule m. Each modification belongs to one of the following three categories
mentioned before:
1. Atom addition. Firstly, we define the set of E be the set of elements a molecule
contains. We then define a valid action as adding (1) an atom in E and (2) a bond
(with all valence-allowed bond orders) between the added atom and the original
molecule wherever possible. For example, with the set of elements E = {C,O}, the
atom addition action set of cyclohexane contains the 4 actions shown in Figure 1a.
Note that hydrogens are considered implicitly, and all atom additions are defined
as replacements of implicit hydrogens.
2. Bond addition. A bond addition action is performed between two atoms with free
valence (not counting implicit hydrogens). If there is no bond between those two
atoms, actions between them consist of adding a single, double, or triple bond
if the valence allows this change. Additional actions increase the bond order
between those two atoms by one or two. In other words, the transitions include:
– No bond → {Single, Double, Triple} Bond.
– Single bond → {Double, Triple} Bond.
– Double bond → {Triple} Bond.
To generate molecules that are chemically more reasonable, we include several
heuristics that incorporate chemistry domain knowledge. First, in order to pre-
vent generating molecules with high strain, we do not allow bond formation be-
tween atoms that are in rings. In addition, we added an option that only allows
formation of rings with a specific number of atoms. In the experiments we have
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done, only rings with 3 to 6 atoms are allowed in consideration of the most com-
mon ring sizes. As an example, Figure 1b shows the allowed bond addition actions
for cyclohexane.
3. Bond removal. We define the valid bond removal action set as the actions that
decrease the bond order of an existing bond. The transitions include:
– Triple bond → {Double, Single, No} Bond.
– Double bond → {Single, No} Bond.
– Single bond → {No} Bond.
Note that bonds are only completely removed if the resulting molecule has zero or
one disconnected atom (and in the latter case, the disconnected atom is removed
as well). Therefore, no molecules having disconnected parts are created in this
step.
(a) Atom addition (b) Bond addition (c) Bond removal
Figure 1: Valid actions on the state of cyclohexane. Modifications are shown in red. Invalid
bond additions which violate the heuristics explained in Section 2.1 are not shown.
In our design choice, we do not break an aromatic bond. However, it is still possible
to break aromaticity. (See the third molecule in Figure 3, w = 0.4; the removal of the
extracyclic double bond from the original molecule breaks aromaticity.) Besides, an
aromatic system can still be created in a stepwise way by adding single and double
bonds alternatively, and the resulting system will be perceived as aromatic by the
RDKit SMILES parser. We also include “no modification” as an action, which allows
the molecule to remain unchanged before reaching the step limitation T .
• {Psa} denotes the state transition probability. Here we define the state transition to
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be deterministic. For example, if we modify a molecule by adding a single bond, the
next state we reach will be the new molecule adding the bond, with a probability of 1.
• R denotes the reward function of state (m, t). In material design or lead optimization,
the reward is often a property of the molecule m. In our design, a reward is given
not just at the terminal states, but at each step, which empirically produces better
learning performance (see Figure S3). To ensure that the final state is rewarded most
heavily, we discount the value of the rewards at a state with time t by γT−t (where we
typically used γ = 0.9). Note that the definition of discount factor is different from the
usual way. In future discussions of reward rt, this discount factor is implicitly included
for simplicity.
Implementation details. We implemented the state transition of a molecule with the
available software framework of RDKit.22 The properties of molecules are calculated with
tools provided by RDKit.
2.2 Reinforcement Learning
Reinforcement Learning is an area of machine learning concerning how the decision makers
(or agents) ought to take a series of actions in a prescribed environment so as to maximize
a notion of cumulative reward, especially when a model of the environment is not available.
Here, the environment is the molecule modification MDP we defined above, and our goal
is to find a policy pi which selects an action for each state that can maximize the future
rewards.
Intuitively, we are trying to fit a function Q(s, a) that predicts the future rewards of
taking an action a on state s. A decision is made by choosing the action a that maximizes
the Q function, which leads to larger future rewards.
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Mathematically, for a policy pi, we can define the value of an action a on a state s to be
Qpi(s, a) = Qpi(m, t, a) = Epi
[
T∑
n=t
rn
]
where Epi denotes taking an expectation with respect to pi, and rn denotes the reward at
step n. This action-value function calculates the future rewards of taking action a on state
s, and subsequent actions decided by policy pi. We can therefore define the optimal policy
pi∗(s) = arg maxaQpi
∗
(s, a).
In our case, however, we have both a deterministic MDP and an accurate model of the
environment. Therefore, we chose to approximate the value function V (s) = maxaQ(s, a)
and we calculate the Q function for an action a moving from state s to s′ as Q(s, a) =
R(s′) + V (s′)
Under the setting that the maximum number of steps is limited, the MDP is time-
dependent, and the optimal policy will be time-dependent as well. Naturally, if there are
many steps left, we can risk pursuing later but larger rewards, while if only a few steps
remain, we should focus on rewards that can be obtained sooner.
We adopt a deep Q-learning20 algorithm to find an estimate of the Q function. We refer
to a neural network function approximator as the parameterized Q-value function Q(s, a; θ),
where θ is the parameter. This approximator can be trained by minimizing the loss function
of
l(θ) = E [fl (yt −Q(st, at; θ))]
where yt = rt + maxaQ(st+1, a; θ) is the target value, and fl is a loss function. In our case,
we use the Huber loss23 as a loss function.
fl(x) =

1
2
x2 if |x| < 1
|x| − 1
2
otherwise
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2.3 Multi-Objective Reinforcement Learning
In real-world applications like lead optimization, it is often desired to optimize several dif-
ferent properties at the same time. For example, we may want to optimize the selectivity of
a drug while keeping the solubility in a specific range. Formally, under the multi-objective
reinforcement learning setting, the environment will return a vector of rewards at each step
t, with one reward for each objective, i.e. ~rt = [r1,t, · · · , rk,t]T ∈ Rk, where k is the number
of objectives.
There exist various goals in multi-objective optimization. The goal may be finding a set
of Pareto optimal solutions, or find a single or several solutions that satisfy the preference
of a decision maker. Similar to the choice in Guimaraes et al. 15 , we adapted the latter one
in this paper. Specifically, we implemented the “scalarized” reward framework to realize
multi-objective optimization, with the introduction of a user defined weight vector w =
[w1, w2 · · · , wk]T ∈ Rk, the scalarized reward can be calculated as
rs,t = w
T ~rt =
k∑
i=1
wiri,t
. The objective of the MDP is then to maximize the cumulative scalarized reward.
2.4 Exploitation vs. Exploration During Training
The trade-off between exploitation and exploration presents a dilemma caused by the uncer-
tainty we face. Given that we do not have a complete knowledge of the rewards for all the
states, if we constantly choose the best action that is known to produce the highest reward
(exploitation), we will never learn anything about the rewards of the other states. On the
other hand, if we always chose an action at random (exploration), we would not receive as
much reward as we could achieve by choosing the best action.
One of the simplest and the most widely used approaches to balance these competing
goals is called ε-greedy, which selects the predicted best action with probability 1− ε, and a
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uniformly random action with probability ε. Without considering the level of uncertainty of
the value function estimate, ε-greedy often wastes exploratory effort on the states that are
known to be inferior.
To counter this issue, we followed the idea of bootstrapped-DQN from Osband et al. 24 by
utilizing randomized value functions to achieve deep exploration. We built H independent
Q-functions {Q(i)|i = 1, · · · , H} (actually, a multi-task neural network with a separate head
for each Q(i); see Section 2.5), each of them being trained on a different subset of the samples.
At each episode, we uniformly choose i ∈ {1, · · · , H}, and use Q(i) for decision making. The
above approach is combined with ε-greedy as our policy. During training, we annealed ε
from 1 to 0.01 in a piecewise linear way.
2.5 Deep Q-Learning Implementation Details
We implemented the deep Q-learning model described by Mnih et al. 20 with improvements of
double Q-learning.25 Recall that a state s is a pair of molecule m and time t. Unsurprisingly,
including t in the model performs better experimentally (see Figure S4).
We used a deep neural network to approximate the Q-function. The input molecule is
converted to a vector form called its Morgan fingerprint26 with radius of 3 and length of
2048, and the number of steps remaining in the episode was concatenated to the vector.
A four-layer fully-connected network with hidden sizes of [1024, 512, 128, 32] and ReLU
activations is used as the network architecture. Its output dimension is the number H (see
above; for computational efficiency, we implemented these H different models as multiple
outputs on top of shared network layers). In most experiments, we limited the maximum
number of steps per episode to 40, given that most drug molecules have less than 40 atoms
(the exception is for the experiments in Section 3.1, where we limit the max number of steps
to be 38 for logP optimization to match You et al. 18 , and Section 3.2, where the limit is
20.). We trained the model for 5,000 episodes with the Adam optimizer27 with a learning
rate of 0.0001. We used ε-greedy together with randomized value functions as a exploration
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policy, and, as mentioned before, we annealed ε from 1 to 0.01 in a piecewise linear way.
The discount factor γ (as defined in Section 2.1) was set to 0.9.
3 Results and Discussion
In these tasks, we demonstrated the effectiveness of our framework on optimizing a molecule
to achieve desired properties. We compared MolDQN with the following state-of-the-art
models:
• Junction Tree Variational Autoencoder (JT-VAE)13 is a deep generative model that
maps molecules to a high-dimensional latent space and performs sampling or optimiza-
tion in the latent space to generate molecules.
• Objective-Reinforced Generative Adversarial Networks (ORGAN)15 is a reinforcement
learning based molecule generation algorithm that uses SMILES strings for input and
output.
• Graph Convolutional Policy Network (GCPN)18 is another reinforcement learning
based algorithm that operates on a graph representation of molecules in combination
with a MDP.
3.1 Single Property Optimization
In this task, our goal is to find a molecule that can maximize one selected property. Similar
to the setup in previous approaches,13,18 we demonstrated the property optimization task
on two targets: penalized logP and Quantitative Estimate of Druglikeness (QED).28 LogP
is the logarithm of the partition ratio of the solute between octanol and water. Penalized
logP13 is the logP minus the synthetic accessibility (SA) score and the number of long cycles.
In this experiment setup, the reward was set to be the penalized logP or QED score of
the molecule. For logP optimization, the initial molecule was set to be empty, while for
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QED optimization, a two-step optimization was used to improve the result. The first step
started with an empty molecule, and the second step started with the 5 molecules that have
the highest QED values found in step one. The max number of steps per episode for LogP
optimization is set to be 38, in order to allow a direct comparison with GCPN. We will
discuss the rationale for this choice in later paragraphs. This number is set to 40 in QED
optimization. We picked the last 100 terminal states in the training process and report the
top three property scores found by each model and the percentage of valid molecules in
Table 1. Note that the range of penalized logP is (−∞,∞), while the range of QED is [0, 1].
We also visualized the best molecules we found in Figure 2. Note that in the optimization
of penalized logP, the generated molecules are obviously not drug-like, which highlights
the importance of carefully designing the reward (including using multiple objectives in a
medicinal chemistry setting) when using reinforcement learning.
We compared our model to three baselines. “Random walk” is a baseline that chooses a
random action for each step, “greedy” is a baseline that chooses the action that leads to the
molecule with the highest reward for each step, and “ε-greedy” follows the “random” policy
with probability ε, and “greedy” policy with probability 1 − ε. Additionally, we compared
our model to three published literature models: ORGAN,15 JT-VAE,13 and GCPN.18
With the introduction of bootstrapped DQN, we are able to find molecules with higher
QED values compared to naive DQN, demonstrating the exploration efficiency of bootstrap-
ping. However, on the task of maximizing penalized logP, bootstrapped DQN does not
provide a significantly better result. This is partly because maximizing logP corresponds to
a simple policy: adding carbon atoms wherever possible. This straightforward policy does
not require much exploration effort, and can be regarded as a greedy policy (Table 1).
Moreover, our experiments reveal that the task of maximizing logP with no constraints
is not a good metric to evaluate the performance of a model. The penalized logP value
almost increases linearly with the number of atoms (Figure S7), therefore it is not fair
to compare logP without limiting the number of atoms to be the same. Although the
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task of optimizing logP can be used to evaluate whether a model can capture the simple
domain-specific heuristic, we suggest that maximization should be performed under certain
constraints, for example, number of atoms, or similarity. We also suggest that targeting a
specific range of logP is also a valid task to evaluate the performance of different models.
This task not only avoids the problem of unconstrained optimization, but also represents a
real need in typical drug discovery projects.
Compared with GCPN, MolDQN demonstrates better performance on the task of logP,
and similar performance on the task of QED. These results can be partly attributed to
learning from scratch, where the scope is not limited to the molecules in a specific dataset.
(a) Optimization of penalized logP (b) Optimization of QED
Figure 2: Sample molecules in the property optimization task. (a) Optimization of penalized
logP from MolDQN-bootstrap; note that the generated molecules are obviously not drug-
like due to the use of a single-objective reward. (b) Optimization of QED from MolDQN-
twosteps.
3.2 Constrained Optimization
We performed molecule optimization under a specific constraint, where the goal is to find a
molecule m that has the largest improvement compared to the original molecule m0, while
maintaining similarity SIM(m,m0) ≥ δ for a threshold δ. Here we defined the similarity
as the Tanimoto similarity1 between Morgan fingerprints26 with radius 2 of the generated
1The Tanimoto similarity uses the ratio of the intersecting set to the union set as the measure of similarity.
Represented as a mathematical equation T (a, b) = NcNa+Nb−Nc . Na and Nb represents the number of attributes
13
Table 1: Top three unique molecule property scores found by each method.
Penalized logP QED
1st 2nd 3rd Validity 1st 2nd 3rd Validity
random walka -3.99 -4.31 -4.37 100% 0.64 0.56 0.56 100%
greedyb 11.41 - - 100% 0.39 - - 100%
ε-greedy, ε = 0.1b 11.64 11.40 11.40 100% 0.914 0.910 0.906 100%
JT-VAEc 5.30 4.93 4.49 100% 0.925 0.911 0.910 100%
ORGANc 3.63 3.49 3.44 0.4% 0.896 0.824 0.820 2.2%
GCPNc 7.98 7.85 7.80 100% 0.948 0.947 0.946 100%
MolDQN-naive 11.51 11.51 11.50 100% 0.934 0.931 0.930 100%
MolDQN-bootstrap 11.84 11.84 11.82 100% 0.948 0.944 0.943 100%
MolDQN-twosteps - - - - 0.948 0.948 0.948 100%
a “random walk” is a baseline that chooses a random action for each step.
b “greedy” is a baseline that chooses the action that leads to the molecule with the highest reward
for each step. “ε-greedy” follows the “random” policy with probability ε, and “greedy” policy
with probability 1− ε. In contrast, the ε-greedy MolDQN models choose actions based on
predicted Q-values rather than rewards.
c values are reported in You et al. 18 .
molecule m and the original molecule m0. Following the experiment in Jin et al.
13 , we
trained a model in an environment whose initial state was randomly set to be one of the
800 molecules in ZINC29 dataset which have the lowest penalized logP value, and ran the
trained model on each molecule for one episode. The maximum number of steps per episode
was limited to 20 in consideration of computational efficiency. In this task, the reward was
designed as follows:
R(s) =

logP(m)− λ× (δ − SIM(m,m0)) if SIM(m,m0) < δ
logP(m) otherwise
where λ is the coefficient to balance the similarity and logP. If the similarity constraint is not
satisfied, the reward is penalized by the difference between the target and current similarity.
In our experiments λ = 100. We report the success rate—the percentage of molecules
satisfying the similarity constraint—as validity, as well as the average improvement on logP
in each object (a, b). Nc is the number of attributes in common.
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in Table 2. Using Welch’s t-test30 for N = 800 molecules, we found that both variants of
MolDQN gives a highly statistically significant improvement over GCPN for all values of δ
with t < −8. The bootstrap variant also significantly outperforms the naive model (except
for δ = 0.2) with t < −3
Table 2: Mean and standard deviation of penalized logP improvement in constraint opti-
mization tasks. δ is the threshold of the similarity constraint SIM(m,m0) ≥ δ. The success
rate is the percentage of molecules satisfying the similarity constraint.
δ
JT-VAEa GCPNa MolDQN-naive MolDQN-bootstrap
Improvement Success Improvement Success Improvement Success Improvement Success
0.0 1.91± 2.04 97.5% 4.20± 1.28 100% 6.83± 1.30 100% 7.04± 1.42 100%
0.2 1.68± 1.85 97.1% 4.12± 1.19 100% 5.00± 1.55 100% 5.06± 1.79 100%
0.4 0.84± 1.45 83.6% 2.49± 1.30 100% 3.13± 1.57 100% 3.37± 1.62 100%
0.6 0.21± 0.71 46.4% 0.79± 0.63 100% 1.40± 1.05 100% 1.86± 1.21 100%
a values are reported in You et al. 18 .
3.3 Multi-Objective Optimization
In drug design, there is often a minimal structural basis that a molecule must retain to
bind a specific target, referred to as the molecular scaffold. This scaffold is usually defined
as a molecule with removal of all side chain atoms.31 Often the question arises: can we
find a molecule similar to a existing one but having a better performance? We designed
the experiment of maximizing the QED of a molecule while keeping it similar to a starting
molecule. The multi-objective reward of a molecule m was set to be a 2-dimensional vector
of ~r = [QED(m), SIM(m,m0)], where QED(m) is the QED score and SIM(m,m0) is the
Tanimoto similarity between the Morgan fingerprints of molecule m and the original molecule
m0.
Different weights w can be applied to denote the priorities of these two objectives. The
variable w denotes the weight of similarity score, while the QED score is balanced by (1−w).
This is referred to as a “scalarized” multi-objective optimization strategy (see Section 2.3):
R(s) = w × SIM(s) + (1− w)×QED(s)
15
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(c)
w = 0.0 w = 0.2
w = 0.4 w = 0.6
w = 0.8 w = 1.0
Figure 3: (a) The QED and Tanimoto similarity of the molecules optimized under different
objective weights. The grey dashed line shows the QED and similarity score of the starting
molecule. The legends are transparent, thus it will not cover any point.(b) The empirical
distribution of the relative QED improvements in 20 multi-objective optimization tasks.
The variable w in legends denotes the weight of the similarity in the multi-objective reward,
while the QED score is weighted by (1− w), i.e. r = w × SIM(s) + (1− w)× QED(s). (c)
Unique molecules sampled from the multi-objective optimization task. The original molecule
is boxed.
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We trained the model with objective weight of 0.0, 0.2, 0.4, 0.6, 0.8, and 1.0, and collected
the last 20 unique molecules generated in the training process to plot the properties of
molecules on a 2-D space. (i.e., there was no separate evaluation step). Figure 3a shows the
properties of the optimized molecules under different weights. Figure 3a demonstrates that
we can successfully optimize the QED of a molecule while keeping the optimized molecule
similar to the starting molecule. As the weight applied on similarity increases, the optimized
molecules have higher similarity to the starting molecule, and larger fractions of the optimized
molecules have QED values lower than those of the starting molecules. The same experiment
was repeated for 20 molecules randomly selected from ChEMBL32 (Figure S1), and the
empirical distribution of the relative improvement of QED was plotted in Figure 3b, where
the relative improvement of molecule m with respect to the original molecule m0 is defined
as
imprel =
QED(m)−QED(m0)
1−QED(m0)
Intuitively, the relative improvement is the ratio of the actual improvement to the largest
possible improvement in QED. The distribution of absolute QED improvement is shown in
Figure S6.
As the weight on similarity increases, the distribution of QED improvements moves left-
wards because higher priority is placed on similarity. Finally, we visually examined the
optimized molecules (Figure 3c). The molecules generated under w >= 0.4 possessed the
same scaffold as the starting molecule, indicating that the trained model preserves the orig-
inal scaffold when the similarity weight is high enough.
3.4 Optimality vs. Diversity
Related work in this area reports results for two distinct tasks: optimization and generation
(or, to avoid ambiguity, property-directed sampling). Optimization is the task to find the
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best molecule with regard to some objectives, whereas property-directed sampling is the task
of generating a set of molecules with specific property values or distributions.
For the results we report in this paper, we note that there is often a trade-off between
optimality and diversity. Without the introduction of randomness, execution of our learned
policy will lead to exactly one molecule. Alternatively, there are three possible ways to
increase the diversity of the molecules generated:
1. Choose one Q function Q(i)(s, a) uniformly for i in 1, · · · , H to make decision in each
episode.
2. Draw an action stochastically with probability proportional to the Q-function in each
step (as in Haarnoja et al. 33).
3. During evaluation, use non-zero ε in the ε-greedy algorithm (we took this approach in
Section 3.3).
All of these strategies are sub-optimal because the policy is no longer pursuing the max-
imum future rewards. In the results above, we focused primarily on optimization tasks and
leave the question of diversity for future work.
We also conducted experiments to illustrate that we are able to find molecules with
properties in specific ranges with 100% success (Table S1). In addition, we demonstrated
that we can generate molecules that satisfy multiple target values (Table S2). However,
because we formulated the property targeting to be an optimization task, it is not fair for
us to compare to other generative models that produce diverse distributions of molecules.
3.5 Visualization and Interpretation
Users prefer interpretable solutions when they applying methods that construct new molecules..
Here we demonstrated the decision making process of MolDQN that maximizes the QED,
starting from a specific molecule.
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Figure 4: (a) Visualization of the Q-values of selected actions. The full set of Q-values of
actions are shown in Figure S2. The original atoms and bonds are shown in black while
modified ones are colored. Dashed lines denote bond removals. The Q-values are rescaled to
[0, 1] (b) The steps taken to maximize the QED starting from a molecule. The modifications
are highlighted in yellow. The QED values are presented under the modified molecules.
In the first step of decision making, the Q-network predicts the Q-value of each action.
Figure 4a shows the predicted Q-values of the chosen actions. The full set of Q-values of
for all actions in the first step are shown in Figure S2. We observe that adding a hydroxyl
group is strongly favored, while breaking the five-member ring structure is disfavored.
Note that the Q-value is a measure of future rewards; therefore, it is possible for the
algorithm to choose an action that decreases the property value in the short term but can
reach higher future rewards. Figure 4b shows a sample trajectory of maximizing the QED
of a molecule. In this trajectory, step 6 decreases the QED of the molecule, but the QED
was improved by 0.297 through the whole trajectory.
4 Conclusion
By combining state-of-the-art deep reinforcement learning with domain knowledge of chem-
istry, we developed the MolDQN model for molecule optimization. We demonstrated that
MolDQN reaches equivalent or better performance when compared with several other estab-
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lished algorithms in generating molecules with better specified properties. We also presented
a way to visualize the decision making process to facilitate learning a strategy for optimizing
molecular design. Future work can be done on applying different Q-function approximators
(for example MPNN34) and hyperparameter searching. We hope the MolDQN model will
assist medicinal and material chemists in molecular design.
As a parting note, it seems obvious to us that the experiments and metrics commonly
employed in the literature (including this work) are inadequate for evaluating and compar-
ing generative models in real-world optimization tasks. In particular, logP is a “broken”
metric that should be discouraged except as a sanity check, and many other commonly used
metrics such as QED suffer from boundary effects that limit comparability. Additionally,
“computable” metrics like QED should be deprioritized in favor of therapeutically relevant
properties that can be verified by experiment—this likely requires incorporating predictive
models based on experiment into generative decision making, as in Li et al. 11 . Even bet-
ter would be to couple these predictions with experimental validation, as has been done by
Merk et al. 35 and Putin et al. 6 . We note that some efforts have been made in addressing
generator evaluation,36 but there remains much work to be done to fairly compare one model
to another on meaningful tasks and make these models relevant and effective in prospective
drug discovery.
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Figure S1: The QED and similarity of the molecules generated under different weights with
different staring molecules. The gray dash line shows the QED and similarity score of the
starting molecule.
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Figure S2: The normalized Q-values of the actions can be taken in the first step. The
original molecule was boxed. Bond addition actions are highlighted while bond removals are
presented as is. The Q-values are rescaled to [0, 1]
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Figure S3: Comparison between the learning curve of the agent while intermediate reward
is given and that when only final reward is given. Here reward is defined as the QED of the
final molecule generated. Bootstrap is turned off in this experiment.
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Figure S4: Comparison of a time-dependent policy and a time-independent policy. Here
reward is defined as the QED of the final molecule generated. Bootstrap is turned off in this
experiment.
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Figure S5: Histogram of number of steps before the policy chooses to stay at the same step
(the “no modification” action, all subsequent actions are “no modification”). (a)The task is
to find a molecule whose molecular weight lies between 150 and 200. (b) The task is to find
a molecule that maximizes the QED. Bootstrap is turned off in this experiment.
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Figure S6: The empirical distribution of the QED improvements in 20 multi-objective op-
timization tasks. The variable w in legends denotes the weight of the similarity in the
multi-objective reward, while the QED score is weighted by (1− w), i.e. r = w × SIM(s) +
(1− w)×QED(s).
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Figure S7: Penalized logP values of acyclic saturated alkane with different number of carbon
atoms.
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S1 Property Targeting
S1.1 Single Property Targeting
It is crucial to find molecules with properties close to a given target in molecule design.
Molecular weight and hydrophobicity are two important properties in drug design related to
drug absorption. Therefore, we chose a target range of molecular weight (MW) and octanol-
water partition coefficient (logP), and measured the percentage of the molecules belonging
to the specified range. Given a target range of [l, u], where l is the lower bound and u is the
upper bound, the reward function of a molecule m is designed as follows:
R(s) =

1 if p(m) ∈ [l, u]
−min{|p(m)− l|, |p(m)− u|} otherwise
(1)
where p(m) is the property value of molecule m. Intuitively, this reward is measuring the
distance between the current property value and the range we define. When the property
value falls into the range we want, a positive reward is given indicating the goal was reached.
Otherwise, the reward is the negative minimum distance the property has to “move” in order
to be in the desired range. The model was trained using the reward defined in Eq. (1), with
the initial molecule being empty. Evaluation was run for 500 episodes, and the properties of
the 500 generated molecules are reported.
Table S1: The success rate of the property targeting task.
-2.5 ≤ logP ≤ -2 5 ≤ logP ≤ 5.5 150 ≤ Mw ≤ 200 500 ≤ Mw ≤ 550
random walka 0.0% 1.0% 0.0% 0.0%
JT-VAEb 11.3% 7.6% 0.7% 16.0%
ORGANb 0.0% 0.2% 15.1% 0.1%
GCPNb 85.5% 54.7% 76.1% 74.1%
ours 100% 100% 100% 100%
a “random walk” is a baseline that chooses a random action for each step.
b values are reported in ?.
Using the same ranges chosen in ?, the effectiveness of the property targeted molecule
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optimization is shown in Table S1. Our model outperforms others by reaching 100% success
rates on all tasks. As stated in ?, the ranges are chosen such that few molecules in ZINC
dataset? are within that range. Compared with other models, our model do not use expert
pretraining on ZINC dataset, therefore the properties of the molecules generated is not
limited by the properties of molecules in ZINC.
Note that since our deterministic policy only leads to 1–3 unique molecules, the success
rates in Table S1 are not comparable. However, this experiment shows that MolDQN is able
to find molecules with arbitrary property values.
S1.2 Multi-Objective Property Targeting
Here we want to illustrate that our model can find optimal molecules that satisfy two con-
straints at the same time. Similar to the experimental setup in ?, the objective is to find
optimal molecules which are close to specific Synthetic Accessibility (SA)? scores and Quan-
titative Estimate of Druglikeness (QED)? values. Here four different targets are specified
as follows: c1 = (2.2, 0.84), c2 = (2.5, 0.27), c3 = (3.8, 0.84), and c4 = (4.8, 0.27), where the
first value is the target SA score and the second is the QED score.
The model was trained using the reward defined below, starting with an empty initial
molecule:
R(s) = −
(∣∣∣QED(m)−QEDtarget∣∣∣+ ∣∣∣SA(m)− SAtarget∣∣∣)
Table S2: Property statistics of the optimized molecules.
Target 1 Target 2 Target 3 Target 4
SAS QED SAS QED SAS QED SAS QED
target value 2.200 0.840 2.500 0.270 3.800 0.840 4.800 0.270
mean a 2.303 0.859 2.564 0.251 3.806 0.834 4.799 0.272
standard deviation a 0.109 0.012 0.114 0.009 0.074 0.012 0.069 0.005
mean absolute difference a 0.103 0.019 0.075 0.020 0.013 0.012 0.009 0.003
a Mean, standard deviation, and mean absolute difference denotes the statistics on unique
generated molecules.
The distributions of SA score and QED for the molecules generated by our model are
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shown in Table S2. Even though SA scores and QED may change significantly with small
modifications of the molecule, the properties of the generated molecules have a narrow dis-
tribution. These results illustrate that explicit rewards on target values can lead to accurate
targeted optimization with reinforcement learning.
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